TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05776654

Intervention type: DEVICE
Intervention: Biometric wearable devices
Description: Passive data collection using biometric wearable devices.
Study: NCT05216874

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Oclusal Splint
Description: Cl III Laterognati volunteer group using occlusal stabilization splint before orthognathic surgery~-Splint will be used for at least two months
Study: NCT06263153

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Durvalumab
Description: Given IV
Study: NCT06263153

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Futibatinib
Description: Given PO

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging
Description: Undergo MRI

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Radical Cystectomy
Description: Undergo radical cystectomy
Study: NCT05852002

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 35 kDa hyaluronan fragment
Description: 100 mg of 35kDa hyaluronan fragment was injected deeply into abdominal fat layer once a day for 28 consecutive days.
Study: NCT06258408

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BB102 tablet
Description: BB102 tablets will be administered orally once daily(QD).
Study: NCT05684029

Intervention type: DEVICE
Intervention: Near-infrared devices
Description: This device can emit and collect near-infrared light of a specific wavelength. The parathyroid glands in the specimen appear as a high-brightness image in the device, to find the parathyroid gland that may be accidentally removed from the specimen.

Intervention type: DIAGNOSTIC_TEST
Intervention: PTH test strip
Description: The PTH test strip is to detect the PTH in the specimen by immunocolloidal gold technology to determine whether it is parathyroid.
Study: NCT05205681

Intervention type: DIAGNOSTIC_TEST
Intervention: Pre-operative imaging
Description: Use of pre-operative imaging or the diagnosis of acute appendicitis

Intervention type: DIAGNOSTIC_TEST
Intervention: Pre-operative imaging
Description: Use of pre-operative imaging or the diagnosis of acute appendicitis
Study: NCT05684029

Intervention type: DIAGNOSTIC_TEST
Intervention: PTH test strip
Description: The PTH test strip is to detect the PTH in the specimen by immunocolloidal gold technology to determine whether it is parathyroid.
Study: NCT05405140

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Shock wave therapy with multiphasic neuroplasticity based training protocol
Description: Interventions program will be based on Activity dependent neuroplasticity targeting relevant impairments included: task specific practice, motor learning, strengthening, postural awareness, Balance training, aerobic and conditioning exercises, range of movement with Shock wave therapy for most of time of the day .
Study: NCT06351111

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Active VNS
Description: Subjects will receive active VNS paired with either of the three rehabilitation trainings
Study: NCT05405140

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional physical therapy
Description: The CP program focused on the facilitation of movements on the paretic side, range of motion, stretching exercises, upper and lower limb strengthening exercises, and improving balance, standing, sitting, transferring, patients received a program for at least 30 sessions, 5 times per week for 6 or more weeks.
Study: NCT06203769

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 14-day antibiotic therapy
Description: The studied intervention will be 14-day antibiotic therapy after removal of infected material

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 28-day antibiotic therapy
Description: The comparator arm will be 28-day antibiotic therapy after removal of infected material
Study: NCT06351111

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Active VNS
Description: Subjects will receive active VNS paired with either of the three rehabilitation trainings

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Active VNS
Description: Subjects will receive active VNS paired with either of the three rehabilitation trainings
Study: NCT06276712

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Implant placement with 3.5 mm diameter KS implants.
Description: Implant placement in edentulous jaws for a prosthetic implant rehabilitation with implant-retained overdenture (mucosally supported), on two implants. with 3.5 mm diameter KS implants.After osseointegration, both dental implants will receive definitive prosthesis.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Implant placement with 3.5 mm diameter TS implants.
Description: Implant placement in edentulous jaws for a prosthetic implant rehabilitation with implant-retained overdenture (mucosally supported), on two implants. with 3.5 mm diameter TS implants.After osseointegration, both dental implants will receive definitive prosthesis.
Study: NCT06017505

Intervention type: DIAGNOSTIC_TEST
Intervention: electronic self administered gerocognitive examination (eSAGE)
Description: A self-administered digital assessment that evaluates multiple cognitive domains: orientation, language, memory, executive function, calculations, abstraction, and visuospatial abilities, through multiple questions. Additionally, it includes the collection of six clinical variables: education, gender, race, family history of dementia, stroke, and emotion.
Study: NCT05997511

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Card-Sorting Activity (Pre-intervention design)
Description: Study team members within each country will free list misinformation or misconceptions that they commonly encounter in clinical practice or daily life. Each item will be used to create paired cards - one containing the misinformation and a second containing the corresponding correct information. During qualitative interviews, we will ask CHWs to participate in a series of card sorting activities, which is a participatory research method that can inform the design of health interventions.

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Card-Sorting Activity (Pre-intervention design)
Description: Study team members within each country will free list misinformation or misconceptions that they commonly encounter in clinical practice or daily life. Each item will be used to create paired cards - one containing the misinformation and a second containing the corresponding correct information. During qualitative interviews, we will ask CHWs to participate in a series of card sorting activities, which is a participatory research method that can inform the design of health interventions.

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: SMS Crafting (Pre-intervention design)
Description: A two-person team consisting of one local communication expert and one clinician will draft clinically correct, easy-to-understand SMS messages designed to counter identified misinformation. We will draft messages that use various styles and use cognitive interviewing with CHWs to assess their understanding of and responses to each style. The final messages used in our intervention will be determined by CHW preference.

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: SMS Crafting (Pre-intervention design)
Description: A two-person team consisting of one local communication expert and one clinician will draft clinically correct, easy-to-understand SMS messages designed to counter identified misinformation. We will draft messages that use various styles and use cognitive interviewing with CHWs to assess their understanding of and responses to each style. The final messages used in our intervention will be determined by CHW preference.

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: SMS Messaging
Description: Final messages will be sent via SMS to all CHWs working in our study area. CHWs will also be provided with contact information for a helpline staffed by a local team member who can answer follow-up questions in the local language.

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: SMS Messaging
Description: Final messages will be sent via SMS to all CHWs working in our study area. CHWs will also be provided with contact information for a helpline staffed by a local team member who can answer follow-up questions in the local language.
Study: NCT05910606

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Digital Exercise
Description: Fall Prevention Program: Our fall- risk reduction program overs digitally delivered exercise with real time feedback from expert instructors.
Study: NCT05322577

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bemarituzumab
Description: Intravenous (IV) infusion

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bemarituzumab
Description: Intravenous (IV) infusion

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bemarituzumab
Description: Intravenous (IV) infusion
Study: NCT05434507

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcatheter Annuloplasty
Description: Under echocardiography guidance, the transcatheter tricuspid annuloplasty system precisely reaches the specified position in the tricuspid valve region via jugular vein and superior vena cava approach. The enlarged tricuspid annular tissue is clamped with the clamp cpart and anchor part to reduce the perimeter of tricuspid annulus, so that the area of tricuspid orifice that could not be coapted is reduced. It plays the purpose of minimally invasive treatment of tricuspid valve.
Study: NCT05140499

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Liposomal bupivacaine
Description: Popliteal nerve block
Study: NCT05322577

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bemarituzumab
Description: Intravenous (IV) infusion
Study: NCT05140499

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bupivacaine Hydrochloride 0.5 % Injectable Solution
Description: Continuous nerve catheter
Study: NCT05273346

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Thermal therapy
Description: After the interferential current therapy, the patient will receive Bohm light for 5 minutes at the site of lumbar spinal stenosis and massage for 5 minutes at low back. Twice a week for 3 months.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Oral painkillers
Description: NSAID drugs, if necessary.
Study: NCT05864989

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Non-incised papila surgical approach only
Description: Reconstructive periodontal surgery

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Non-incised papila surgical approach with connective tissue grafting
Description: Reconstructive periodontal surgery
Study: NCT05881434

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Emergency Department Visit Expectations Questionnaire
Description: Patients presented with novel questionnaire designed to illicit patient's self-reported expectations across four domains (overall purpose of visit, medication intervention, imaging intervention and disposition) during check-in when arriving at the emergency department. Patients instructed to present the completed questionnaire to the treating provider.
Study: NCT05322577

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CAPOX
Description: CAPOX administered as a combination of oxaliplatin as an IV infusion and capecitabine orally as tablets.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CAPOX
Description: CAPOX administered as a combination of oxaliplatin as an IV infusion and capecitabine orally as tablets.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SOX
Description: SOX administered as a combination of oxaliplatin as an IV infusion and S-1 orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SOX
Description: SOX administered as a combination of oxaliplatin as an IV infusion and S-1 orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nivolumab
Description: IV infusion.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nivolumab
Description: IV infusion.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nivolumab
Description: IV infusion.
Study: NCT05526937

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Bread
Description: Bread portions of 50 gram available carbohydrates.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Bread
Description: Bread portions of 50 gram available carbohydrates.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Bread
Description: Bread portions of 50 gram available carbohydrates.
Study: NCT06551194

Intervention type: OTHER
Intervention: prevalence of difficult-to-treat IBD
Description: To assess the prevalence and risk factors of difficult-to-treat IBD patients

Intervention type: OTHER
Intervention: prevalence of difficult-to-treat IBD
Description: To assess the prevalence and risk factors of difficult-to-treat IBD patients
Study: NCT05882487

Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: KL002 injection solution
Description: Neurosurgical delivery of KL002 to the brain
Study: NCT06056141

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Misoprostol 200mcg Tab
Description: Misoprostol 200 mcg dissolvedwith 200 ml water and divided to 25ml solution every 2 hours per os for maximum of 8 doses

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Foley Catheter
Description: Transcervical Foley catheter (silicone, size 20F with 30ml balloon)
Study: NCT06263452

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Propranolol
Description: Tablet encapsulated to visually look identical to the placebo.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Encapsulated sugar pill to visually look identical to the experimental condition.
Study: NCT05964036

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: active TMS
Description: Participants will receive 10 sessions per day of 1800 pulses per session, lasting for 5 days. Individualized target in the DMPFC will be generated using the pBFS method
Study: NCT06054035

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dapagliflozin (Forxiga®)
Description: Dapagliflozin 10 mg once daily for 2 years. Route of administration: oral.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo matching Dapaglifolzin
Description: Placebo matching Dapaglifolzin once daily for 2 years. Route of administration: oral.
Study: NCT05964036

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: sham TMS
Description: The parameters in the sham arm are the same as in the active stimulation group. Stimulation was delivered by the same device as the active group fitted with a sham coil
Study: NCT05657301

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: KH631
Description: KH631: AAV vector containing a coding sequence for an anti-VEGF protein

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: KH631
Description: KH631: AAV vector containing a coding sequence for an anti-VEGF protein

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: KH631
Description: KH631: AAV vector containing a coding sequence for an anti-VEGF protein

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: KH631
Description: KH631: AAV vector containing a coding sequence for an anti-VEGF protein

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: KH631
Description: KH631: AAV vector containing a coding sequence for an anti-VEGF protein
Study: NCT05486715

Intervention type: DRUG
Intervention: Vit D
Description: Vit D

Intervention type: DRUG
Intervention: Vit D
Description: Vit D
Study: NCT06245850

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Baduanjin
Description: chinese baduanjin

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Rational emotive behavior therapy
Description: Rational emotive behavior therapy
Study: NCT04964882

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: ultrasound examination of air insufflation in the upper esophageal region and stomach
Description: Presence of air insufflation is assessed using ultrasound in the upper esophageal region and stomach during face mask ventilation

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: ultrasound examination of air insufflation in the upper esophageal region and stomach
Description: Presence of air insufflation is assessed using ultrasound in the upper esophageal region and stomach during face mask ventilation

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: ultrasound examination of air insufflation in the upper esophageal region and stomach
Description: Presence of air insufflation is assessed using ultrasound in the upper esophageal region and stomach during face mask ventilation

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: ultrasound examination of air insufflation in the upper esophageal region and stomach
Description: Presence of air insufflation is assessed using ultrasound in the upper esophageal region and stomach during face mask ventilation

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: ultrasound examination of air insufflation in the upper esophageal region and stomach
Description: Presence of air insufflation is assessed using ultrasound in the upper esophageal region and stomach during face mask ventilation
Study: NCT06441149

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: AI-based informed consent
Description: Patients receiving personalized data-based informed consent procedure before bronchoscopy

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Standard informed consent
Description: Standard informed consent
Study: NCT04908358

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Active transcutaneous vagus nerve stimulation respiratory-gated non-painful electrical stimulation of the auricle for 10 minute sessions
Description: Stimulation of vagus nerve in the outer ear

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Active transcutaneous vagus nerve stimulation respiratory-gated non-painful electrical stimulation of the auricle for 10 minute sessions
Description: Stimulation of vagus nerve in the outer ear

Intervention type: OTHER
Group type: OTHER
Intervention: Active transcutaneous vagus nerve stimulation respiratory-gated non-painful electrical stimulation of the auricle for 10 minute sessions
Description: Stimulation of vagus nerve in the outer ear

Intervention type: OTHER
Group type: OTHER
Intervention: Active transcutaneous vagus nerve stimulation respiratory-gated non-painful electrical stimulation of the auricle for 10 minute sessions
Description: Stimulation of vagus nerve in the outer ear

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham transcutaneous vagus nerve stimulation respiratory-gated non-painful electrical stimulation of the auricle for 10 minute sessions
Description: Sham stimulation of vagus nerve in the outer ear

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham transcutaneous vagus nerve stimulation respiratory-gated non-painful electrical stimulation of the auricle for 10 minute sessions
Description: Sham stimulation of vagus nerve in the outer ear
Study: NCT06054035

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Lifestyle Intervention
Description: Patients receive a conventional lifestyle intervention (one in depth individual session at the beginning and standard care information on a healthy lifestyle at every visit thereafter).
Study: NCT04908358

Intervention type: OTHER
Group type: OTHER
Intervention: Sham transcutaneous vagus nerve stimulation respiratory-gated non-painful electrical stimulation of the auricle for 10 minute sessions
Description: Sham stimulation of vagus nerve in the outer ear
Study: NCT06054035

Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Lifestyle Intervention
Description: Patients receive a conventional lifestyle intervention (one in depth individual session at the beginning and standard care information on a healthy lifestyle at every visit thereafter).
Study: NCT05975528

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SGLT2 inhibitor
Description: For the SGLT2 inhibitor group, total drug adminstration days are 180 days, but non-SGLT2 inhibitor administration period is 3 months, and then changed to the SGLT2 inhibitor another 3 months.~For the SGLT2 inhibitor group, empagliflozin 10mg or dapagliflozin 10mg once daily is administered.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Glimepiride
Description: For non-SGLT2 inhibitor (glimepiride) administration period is 3 months, and then changed to the SGLT2 inhibitor another 3 months.
Study: NCT05243095

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Computer assited, game-based cognitive training
Description: After recording the demographic information of the participants, the Stroop Test was applied to evaluate attention. After the stages of the test were explained to the participants in detail, they were shown once in practice.~The training group received 20 minutes of cognitive training every day for 8 weeks. No training was applied to the control group. Groups were evaluated at baseline and after 8 weeks.
Study: NCT06366880

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Parenteral nutrition cycling
Description: This study is a single-centre, non-blinded RCT in the NICU of Pediatric Hospital of Sinaloa, Northwest, Mexico.~A total of 66 infants born ≥34 weeks of gestation who have a high likelihood of intolerance to enteral nutrition (EN) for at least 10 days will be randomised to PNC o PNT after informed parental consent. In both groups, EN will be commenced as early as clinically feasible.
Study: NCT04634279

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Collaborative care Plus
Description: Collaborative care consists of a team of providers that includes a care coordinator, a primary care provider (PCP) and a behavioral health consultant (BHC), who provide evidence- and measurement-based care to a panel of patients using a clinical registry. In this model, the CC team also includes a behavioral health psychotherapist (BHP) who consults on a regular basis but does not deliver direct care. In the Collaborative Care Plus condition, the care coordinator involves family in care, teaches family about naloxone use, and provides Caring Contacts, a suicide prevention method, to patients.